In brief

April 2016   Comments

New hope for treating multiple myeloma

A novel therapeutic approach is producing promising results for the treatment of multiple myeloma, a cancer of the bone marrow that cannot be cured with conventional chemotherapy. Average life expectancy for people with the disease is six to seven years. The new regimen was developed by a team from the University of Montreal and Maisonneuve-Rosemont Hospital and involves transplantation of stem cells and immunotherapy. Ninety-two patients were followed for a median of 8.8 years after undergoing the new treatment. The study, published in Bone Marrow Transplantation, resulted in a total cure rate of 41 per cent.

< 1 2 3 4 5  
comments powered by Disqus